4//SEC Filing
Henderson Molly 4
Accession 0001209191-23-023749
CIK 0001783183other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 3:18 PM ET
Size
5.7 KB
Accession
0001209191-23-023749
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-04-06$7.27/sh−3,439$25,002→ 72,576 total
Holdings
- 338.86(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 3:18 PM ET
- Size
- 5.7 KB